Chemical Biology Research Center (화학생물연구센터)
Results 1-20 of 72 (Search time: 0.001 seconds).
No. | Year | Title | Type |
---|---|---|---|
72 | 2025 | 2025Research Project 일차섬모 다이나믹스 기반 폐암 약물저항성 극복 선도물질 발굴 및 작용기전 규명 = Development of lead compounds and identification of mechanisms to overcome drug resistance in lung cancer based on primary ci연구책임자 : 이경호 / 사업기간 : 2025.05.01 ~ 2026.04.30 |
Research Project |
71 | 2025 | 2025Research Project TME 면역저항성 조절용 막단백질 발현 세포주 구축 및 활용연구책임자 : 조희준 / 사업기간 : 2025.01.01 ~ 2025.12.31 |
Research Project |
70 | 2025 | 2025Research Project 미래대응형 차세대 미생물 천연물 기반 혁신 의약활성 소재 개발 및 사업화 = Development and Commercialization of Future-Oriented Microbial Natural Product-Based Innovative Bioactive Substances연구책임자 : 장재혁 / 사업기간 : 2025.01.01 ~ 2025.12.31 |
Research Project |
69 | 2024 | Report | |
68 | 2024 | Patent | |
67 | 2024 | 2024Report 암세포 약물내성 극복을 위한 실리오제네시스 융합클러스터 = Ciliogenesis convergence cluster for cancer cell drug resistance solution'연구책임자 : 이경호 / 주관부처 : 국가과학기술연구회이경호; 조희준; 김문옥; 권태호 |
Report |
66 | 2024 | 2024Report 일차섬모가 유발하는 항암제 내성 기전 발굴 = Discovery of a novel primary cilium-induced anti-cancer drug resistance mechanism연구책임자 : 이경호 / 주관부처 : 과학기술정보통신부이경호; 이나경 |
Report |
65 | 2024 | 2024Research Project 일차섬모 다이나믹스 기반 폐암 약물저항성 극복 선도물질 발굴 및 작용기전 규명 = Development of lead compounds and identification of mechanisms to overcome drug resistance in lung cancer based on primary ci연구책임자 : 이경호 / 사업기간 : 2024.05.01 ~ 2025.04.30 |
Research Project |
64 | 2024 | 2024Article NEK2 phosphorylates RhoGDI1 to promote cell proliferation, migration and invasion through the activation of RhoA and Rac1 in colon cancer cellsCells, vol. 13, no. 24, pp. 2072-2072Jeewon Lim; Yo Sep Hwang; Jong-Tae Kim; Hyang Ran Yoon; Hyo-Min Park; Jahyeong Han; Taeho Kwon; Kyung Ho Lee; Hee Jun Cho; Hee Gu Lee |
Article |
63 | 2024 | 2024Research Project 혁신 항암기작 기반 항암물질 개발 기술 구축 = Discovery of First-In-Class Anticancer Agents through Innovative Cancer Target Strategy연구책임자 : 장재혁 / 사업기간 : 2024.01.01 ~ 2024.12.31 |
Research Project |
62 | 2024 | 2024Research Project TME 면역저항성 조절용 막단백질 발현 세포주 구축 및 활용연구책임자 : 조희준 / 사업기간 : 2024.01.01 ~ 2024.12.31 |
Research Project |
61 | 2024 | 2024Article Cisplatin induces kidney cell death via ROS-dependent MAPK signaling pathways by targeting peroxiredoxin I and II in African Green Monkey (Chlorocebus aethiops sabaeus) kidney cellsin Vivo, vol. 38, no. 2, pp. 630-639H N Zhang; W Q Xiao; D H Lee; N Li; Y Y Feng; T Su; H Y Gu; Ijoo Yoon; Haiyoung Jung; Kyung Ho Lee, et al. |
Article |
60 | 2024 | 2024Article Transport of Golgi-localized β-catenin p-S47 by KIF11 or KIFC3 induces primary ciliogenesisMolecules and Cells, vol. 47, no. 12, pp. 100142-100142Na Yeong Lee; M R Kyun; J E Yu; S O Kim; K H Lim; Kyung Ho Lee |
Article |
59 | 2023 | Patent | |
58 | 2023 | Patent | |
57 | 2023 | Patent | |
56 | 2023 | 2023Research Project 일차섬모가 유발하는 항암제 내성 기전 발굴 = Discovery of a novel primary cilium-induced anti-cancer drug resistance mechanism연구책임자 : 이경호 / 사업기간 : 2023.03.01 ~ 2024.02.29 |
Research Project |
55 | 2023 | 2023Research Project 혁신 항암기작 기반 항암물질 개발 기술 구축 = Discovery of First-In-Class Anticancer Agents through Innovative Cancer Target Strategy연구책임자 : 장재혁 / 사업기간 : 2023.01.01 ~ 2023.12.31 |
Research Project |
54 | 2023 | 2023Research Project 암세포 약물내성 극복을 위한 실리오제네시스 융합클러스터 = Ciliogenesis convergence cluster for cancer cell drug resistance solution연구책임자 : 이경호 / 사업기간 : 2023.11.01 ~ 2024.10.31 |
Research Project |
53 | 2023 | 2023Article Peroxiredoxin II regulates exosome secretion from dermal mesenchymal stem cells through the ISGylation signaling pathwayCell Communication and Signaling, vol. 21, pp. 296-296Y H Han; Y Y Mao; Kyung Ho Lee; Hee Jun Cho; N N Yu; X Y Xing; A G Wang; M H Jin; K S Hong; H N Sun, et al. |
Article |